TickerFactsScreenerDevelopers

Galera Therapeutics, Inc. (GRTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$22.17M2019: -$46.66M2020: -$59.54M2021: -$67.96M2022: -$43.43M2023: -$44.85M2024: -$12.14M2025: -$6.05M-$6.05M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.05M+50.2%
2024-$12.14M+72.9%
2023-$44.85M-3.3%
2022-$43.43M+36.1%
2021-$67.96M-14.1%
2020-$59.54M-27.6%
2019-$46.66M-110.5%
2018-$22.17M—